We are live on ! Find out more
ERNA icon

Eterna Therapeutics
ERNA

11 hedge funds and large institutions have $1.19M invested in Eterna Therapeutics in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.03% more ownership

Funds ownership: 0% → 0.03% (+0.03%)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

51% less capital invested

Capital invested by funds: $2.44M → $1.19M (-$1.25M)

65% less funds holding

Funds holding: 31 → 11 (-20)

86% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 22

Holders
11
Holders Change
-20
Holders Change %
-64.52%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
22
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CPWM
Cypress Point Wealth Management
Texas
+$355K
2
NW
Naviter Wealth
Arkansas
+$299K
3
AWS
AJ Wealth Strategies
New York
+$128K
4
BWP
Baldwin Wealth Partners
Massachusetts
+$28.2K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$5.64K

Top Sellers

Rank Fund Capital Flow
1
LSAG
Lake Street Advisors Group
New Hampshire
-$604K
2
AC
Armistice Capital
New York
-$274K
3
Renaissance Technologies
Renaissance Technologies
New York
-$209K
4
Millennium Management
Millennium Management
New York
-$207K
5
Vanguard Group
Vanguard Group
Pennsylvania
-$56.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
26
Goldman Sachs
New York
– -$19K -10 Closed
VF
27
Virtu Financial
New York
– -$16K -8 Closed
Bank of New York Mellon
28
Bank of New York Mellon
New York
– -$12K -7 Closed
Citadel Advisors
29
Citadel Advisors
Florida
– -$13K -7 Closed
Northern Trust
30
Northern Trust
Illinois
– -$12K -7 Closed
Man Group
31
Man Group
United Kingdom
– -$10K -6 Closed
SCA
32
Sippican Capital Advisors
Massachusetts
– -$9K -5 Closed
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
– -$8K -5 Closed
TRCT
34
Tower Research Capital (TRC)
New York
– -$5.64K -4 -80%
CSS
35
Cubist Systematic Strategies
Connecticut
– -$6K -3 Closed
AFG
36
Allegheny Financial Group
Pennsylvania
– -$2K -2 Closed
BCM
37
Bridgeway Capital Management
Texas
– -$3K -2 Closed
Qube Research & Technologies (QRT)
38
Qube Research & Technologies (QRT)
United Kingdom
– -$4K -2 Closed
TSS
39
Two Sigma Securities
New York
– -$4K -2 Closed
UBS Group
40
UBS Group
Switzerland
– -$3K -2 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
– -$1K -1 Closed
AWS
42
AJ Wealth Strategies
New York
– +$128K +91 +1,820%
1
2

ERNA Hedge Fund Activity: Q4 2022 in Review

11 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Eterna Therapeutics (ERNA) for Q4 2022, worth a combined $1.19M — down 51% from $2.44M a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of ERNA and 3 opened new positions — a net loss of 19 holders — while 4 trimmed existing stakes and 4 added.

The largest buyer was Cypress Point Wealth Management, opening a new position worth an estimated $355K. The largest seller was Lake Street Advisors Group, exiting entirely with an estimated $604K sold.

  • 11 institutional investors held Eterna Therapeutics (ERNA) as of Q4 2022, down from 31 in Q3 2022.
  • Funds reported $1.19M of Eterna Therapeutics stock for Q4 2022, down 51% quarter-over-quarter.
  • 3 funds opened new Eterna Therapeutics positions in Q4 2022 and 22 closed out, a net change of -19 holders.
  • The largest Eterna Therapeutics buyer in Q4 2022 was Cypress Point Wealth Management, an estimated $355K added.
  • The largest Eterna Therapeutics seller in Q4 2022 was Lake Street Advisors Group, an estimated $604K sold.

Based on aggregated 13F filings for Q4 2022.